Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vision Research|April 17, 2017
The pathology associated with diabetic retinopathyJudith Lechner, Olivia E O'Leary, Alan W Stitt
Clinical Ophthalmology (Auckland, N.Z.)|February 11, 2025
Human Factors Studies to Assess the Usability of the Faricimab Prefilled SyringeMark R Barakat, Henry M Kwong, Gelson Marcon, et al.
Investigative Ophthalmology & Visual Science|July 20, 2018
Tear Film Proteomics Reveal Important Differences Between Patients With and Without Ocular GvHD After Allogeneic Hematopoietic Cell TransplantationNadine Gerber-Hollbach, Kim Plattner, Olivia E O'Leary, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 29, 2025
POYANG: A phase III randomized clinical trial of faricimab for choroidal neovascularization secondary to pathologic myopia: study design and rationaleTimothy Y Y Lai, Luis Arias, Chui Ming Gemmy Cheung, et al.
Experimental Eye Research|March 17, 2019
The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimeticOlivia E O'Leary, Paul Canning, Emma Reid, et al.
Translational Vision Science & Technology|September 4, 2020
Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease ClassificationOlivia E O'Leary, Andreas Schoetzau, Ludovic Amruthalingam, et al.
Ophthalmology|January 14, 2026
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension TrialVeeral S Sheth, Patricio Schlottmann, Timothy Y Y Lai, et al.
The Ocular Surface|June 7, 2020
TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseasesSusan Erickson, Amy Gallant Sullivan, Stefano Barabino, et al.
Pageof 1